LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

Начало・Списък с акции・Medtronic PLC

Search

Medtronic PLC

Затворен

СекторЗдравеопазване

78.65 0.83

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

78.61

Максимум

78.91

Ключови измерители
By Trading Economics
Приходи	-231M 1.1B
Продажби	57M 9B
P/E Средно за сектора	21.598 49.701
EPS	0.89
Дивидентна доходност	3.72
Марж на печалбата	12.675
Служители	95,000
EBITDA	124M 2.5B

Препоръки
By TipRanks
Препоръки	Купи
12-месечна прогноза	+33.44% upside

Дивиденти
By Dow Jones
Дивидентна доходност Средно за сектора	3.72% 2.39%
Следващи печалби	3.06.2026 г.
Следваща дата на дивидент	10.07.2026 г.
Следваща дата на екс-дивидент	26.06.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	-28B 99B
Предишно отваряне	77.82
Предишно затваряне	78.65

Настроения в новините

By Acuity

29%

71%

60 / 345 Класиране в Healthcare

Medtronic PLC Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

20.05.2026 г., 13:49 ч. UTC

Придобивния, сливания и поглъщания

Medtronic to Buy SPR Therapeutics for About $650 Million

10.03.2026 г., 11:19 ч. UTC

Придобивния, сливания и поглъщания

Medtronic to Buy Scientia Vascular in $550 Million Deal

17.02.2026 г., 12:43 ч. UTC

Печалби

Medtronic 3Q Profit Falls Despite Higher Revenue

20.05.2026 г., 13:15 ч. UTC

Придобивния, сливания и поглъщания

Medtronic Announces Intent To Acquire SPR Therapeutics, Inc., Expanding Care Options For People Living With Chronic Pain >MDT

20.05.2026 г., 13:15 ч. UTC

Придобивния, сливания и поглъщания

Medtronic to Buy SPR Therapeutics for About $650 Million in Cash >MDT

22.04.2026 г., 11:27 ч. UTC

Печалби

Intuitive Surgical Earnings Show Big Beats Don't Always Spark Stock Rallies -- Barrons.com

20.04.2026 г., 11:50 ч. UTC

Придобивния, сливания и поглъщания

Medtronic Completes Acquisition Of CathWorks, Expanding Its Leadership In Transforming Care For Patients With Cardiovascular Disease >MDT

24.03.2026 г., 20:59 ч. UTC

Печалби

Medtronic PLC Cuts FY26 View To Adj EPS $5.50-Adj EPS $5.54 >MDT

10.03.2026 г., 10:46 ч. UTC

Придобивния, сливания и поглъщания

Medtronic: Scientia Deal Complements Neurovascular Portfolio >MDT

10.03.2026 г., 10:46 ч. UTC

Придобивния, сливания и поглъщания

Medtronic: Scientia Deal Includes Potential Undisclosed Earn-Out, Milestone Payments >MDT

10.03.2026 г., 10:45 ч. UTC

Придобивния, сливания и поглъщания

Medtronic: Scientia Vascular Acquisition Valued at $550 Million >MDT

10.03.2026 г., 10:45 ч. UTC

Придобивния, сливания и поглъщания

Medtronic to Acquire Scientia Vascular >MDT

17.02.2026 г., 21:21 ч. UTC

Печалби

These Stocks Are Today's Movers: Paramount, Masimo, Medtronic, Kyndryl, eToro, Genuine Parts, Southwest, and More -- Barrons.com

17.02.2026 г., 18:11 ч. UTC

Печалби

Medtronic Posts Better-Than-Expected Earnings. Here's Why the Stock Is Falling. -- Barrons.com

17.02.2026 г., 14:48 ч. UTC

Печалби

Medtronic Posts Better-Than-Expected Earnings. Here's Why the Stock Is Falling. -- Barrons.com

17.02.2026 г., 13:00 ч. UTC

Печалби

Medtronic Posts Better-Than-Expected Earnings. Here's Why the Stock Is Falling. -- Barrons.com

17.02.2026 г., 12:05 ч. UTC

Печалби

Medtronic Posts Better-Than-Expected Earnings. Here's Why the Stock Is Falling. -- Barrons.com

17.02.2026 г., 11:47 ч. UTC

Печалби

Medtronic Sees 2026 EPS up 4.5%, Excluding Potential Impact From Tariffs >MDT

17.02.2026 г., 11:47 ч. UTC

Печалби

Medtronic Still Sees FY26 Organic Revenue Up About 5.5% >MDT

17.02.2026 г., 11:46 ч. UTC

Печалби

Medtronic FY26 View Includes Potential Impact From Tariffs of About $185M >MDT

17.02.2026 г., 11:46 ч. UTC

Печалби

Medtronic Backs FY26 View of Adj EPS $5.62-Adj EPS $5.66 >MDT

17.02.2026 г., 11:46 ч. UTC

Печалби

Medtronic Reiterates FY26 Organic Rev Growth, EPS Guidance >MDT

17.02.2026 г., 11:45 ч. UTC

Печалби

Medtronic 3Q Adj EPS $1.36 >MDT

17.02.2026 г., 11:45 ч. UTC

Печалби

Medtronic 3Q Neuroscience Portfolio Rev $2.56B >MDT

17.02.2026 г., 11:45 ч. UTC

Печалби

Medtronic 3Q Organic Revenue Up 6.0% >MDT

17.02.2026 г., 11:45 ч. UTC

Печалби

Medtronic 3Q Sales $9.02B >MDT

17.02.2026 г., 11:45 ч. UTC

Печалби

Medtronic 3Q Diabetes Rev $796M >MDT

17.02.2026 г., 11:45 ч. UTC

Печалби

Medtronic 3Q Cardiovascular Portfolio Rev $3.46B >MDT

17.02.2026 г., 11:45 ч. UTC

Печалби

Medtronic 3Q Medical Surgical Portfolio Rev $2.17B >MDT

17.02.2026 г., 11:45 ч. UTC

Печалби

Medtronic 3Q Net $1.14B >MDT

Сравнение с други в отрасъла

Ценова промяна

Medtronic PLC Прогноза

Ценова цел

By TipRanks

33.44% нагоре

12-месечна прогноза

Среден 104.88 USD 33.44%

Висок 120 USD

Нисък 84 USD

Според 18 анализатори от Wall Street, предложили 12-месечна ценова цел за Medtronic PLC през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

18 ratings

11

Купи

7

Задържане

0

Продай

Според 18 анализатори, дали борсови рейтинги на Medtronic PLC през последните 3 месеца.

Настроение

By Acuity

60 / 345 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Medtronic PLC

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists; and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat other non-exclusive diseases and conditions; and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems, and InPen, a smart insulin pen system. The company was founded in 1949 and is headquartered in Galway, Ireland.

Други акции от сектора

LLY

Eli Lilly and Co.

1,066.82

JNJ

Johnson and Johnson

234.57

ABBV

AbbVie Inc

216.12

UNH

UnitedHealth Group Inc

388.17

AZN

AstraZeneca PLC

187.25

Live chat